⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Remedy & Company Corporation and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Remedy & Company Corporation
↗Tokyo, Japan
Remedy & Company Corporation is a global health-tech platform and Contract Research Organization (CRO) headquartered in Tokyo, Japan. Formerly known as intellim Holdings Corporation, the company rebranded in 2022 to reflect its expansion beyond traditional CRO services into digital health, decentralized clinical trials (DCT), and advanced medical solutions.
The company operates as a group, overseeing subsidiaries including intellim Corporation, iRIS Corporation, Quantum Healthcare Corporation, and Remedy XR Corporation. Its mission focuses on leveraging technology, such as XR (VR/AR/MR) and metaverse planning, to innovate global clinical trial environments and improve healthcare outcomes across Asia, Africa, and Australia.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:CRO
Sub-Industry:Clinical Research Organization / Health Tech
SIZE & FINANCIALS
Employees:1-50
Founded:2005
Ownership:private
Status:operating
FUNDING
Stage:Pre-IPO
PIPELINE
Stage:Discovery
Lead Drug Stage:N/A (Service Provider)
Modalities:Digital Health, Clinical Trial Systems
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:intellim Corporation, iRIS Corporation, Quantum Healthcare Corporation, Remedy XR Corporation
Key Partnerships:GHIT Fund (Funding Partner for global health initiatives)
COMPETITION
Position:Niche Player
Competitors:PAREXEL, IQVIA, EPS Group
LEADERSHIP
Key Executives:
Masakuni Ukita - Founder and CEO
LINKS
Website:remedy-company.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Remedy & Company Corporation. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.